Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Pediatrics
Published in: European Journal of Pediatrics 2/2009

01-02-2009 | Original Paper

Drug utilisation profile in the Italian paediatric population

Authors: Antonio Clavenna, Alessandra Berti, Lucia Gualandi, Elisa Rossi, Marisa De Rosa, Maurizio Bonati

Published in: European Journal of Pediatrics | Issue 2/2009

Login to get access

Abstract

Objective

In order to evaluate the prescribing pattern in the Italian paediatric population, prescriptions involving 923,353 children under 14 years old and dispensed during 2006 by the retail pharmacies of 22 Italian local health units were analysed.

Materials and methods

A total of 561,237 children (61%) received at least one drug prescription. The prescription prevalence rate was highest in children 3 years of age (78%), decreased with increasing age and was higher in boys than in girls (χ2 = 655; p << 0.001). Each treated child received an average of 3.2 prescriptions and 4.8 boxes.

Results

Antibiotics and anti-asthmatics were the more prescribed therapeutic classes and represented 80% of prescriptions. Amoxicillin+clavulanic acid was the most prescribed drug (24% of the overall population; 17% of all boxes), followed by inhaled beclometasone and amoxicillin. A total of 620 different drugs were prescribed and the ten leading drugs represented 64% of the prescribed boxes. Six of the ten most prescribed drugs were the same in all age groups. Wide differences were found in the prevalence rate between the different local health units; these ranged between 50.1 and 68.4% (p << 0.001). The prescription prevalence increased in the 2000–2002 period (from 62.2 to 68.3%) and slightly decreased afterwards.

Conclusion

Despite some limitations, the systematic monitoring of prescriptions is a valuable tool for evaluating the appropriateness of the care.
Literature
1.
Abi Khaled L, Ahmad F, Brogan T, Fearnley J, Graham J, MacLeod S, McCormick J (2003) Prescription medicine use by one million Canadian children. Paediatr Child Health 8(Suppl A):6A–56A
2.
American Academy of Pediatrics. Subcommittee on Management of Sinusitis and Committee on Quality Improvement (2001) Clinical practice guideline: management of sinusitis. Pediatrics 108:798–808
3.
American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media (2004) Diagnosis and management of acute otitis media. Pediatrics 113:1451–1465CrossRef
4.
Barbato A, Panizzolo C, Biserna L, Cantarutti L, Giaquinto C, Frati F, Marcucci F, Monciotti C, Testi R, di Blasi P, Sturkenboom MC; Pedianet Family Pediatricians Asthma Study Group (F-PASG) (2003) Asthma prevalence and drug prescription in asthmatic children. Eur Ann Allergy Clin Immunol 35:47–51PubMed
5.
Beimfohr C, Maziak W, von Mutius E, Hense HW, Leupold W, Hirsch T, Keil U, Weiland SK (2001) The use of anti-asthmatic drugs in children: results of a community-based survey in Germany. Pharmacoepidemiol Drug Saf 10:315–321PubMedCrossRef
6.
Bonati M (1994) Epidemiologic evaluation of drug use in children. J Clin Pharmacol 34:300–305PubMed
7.
Bonati M, Clavenna A, Rocchi F (2001) Corticosteroidi in età pediatrica. Marketing e prescrizione. Informazioni sui Farmaci 2–3:79–82
8.
Borgnolo G, Simon G, Francescutti C Lattuada L, Zanier L (2001) Antibiotic prescription in Italian children: a population-based study in Friuli Venezia Giulia, north-east Italy. Acta Paediatr 90:1316–1320PubMedCrossRef
9.
Cazzato T, Pandolfini C, Campi R, Bonati M; ACP Puglia-Basilicata Working Group (2001) Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 57:611–616PubMedCrossRef
10.
Choonara I, Nunn AJ, Kearns G (eds) (2003) Introduction to paediatric and perinatal drug therapy. Nottingham University Press, Nottingham, UK
11.
Cincinnati Children’s Hospital Medical Center (2006) Evidence-based care guideline for management of acute bacterial sinusitis in children 1–18 years of age. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 7 July 2006
12.
Clavenna A, Rossi E, Berti A Pedrazzi G, De Rosa M, Bonati M; ARNO Working Group (2003) Inappropriate use of anti-asthmatic drugs in the Italian paediatric population. Eur J Clin Pharmacol 59:565–569PubMedCrossRef
13.
Clavenna A, Bonati M, Rossi E, Berti A, De Rosa M (2004) Il profilo prescrittivo della popolazione pediatrica italiana nelle cure primarie. Ric Prat 20:224–244
14.
Furu K, Skurtveit S, Langhammer A, Nafstad P (2007) Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 63:693–698PubMedCrossRef
15.
Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML (2005) A three-year population-based study of antibiotic treatments for children. Acta Paediatr 94:1502–1504PubMedCrossRef
16.
Galassi C, De Sario M, Biggeri A, Bisanti L, Chellini E, Ciccone G, Petronio MG, Piffer S, Sestini P, Rusconi F, Viegi G, Forastiere F (2006) Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994–2002. Pediatrics 117:34–42PubMedCrossRef
17.
18.
Goodman DC, Lozano P, Stukel TA, Chang Ch, Hecht J (1999) Has asthma medication use in children become more frequent, more appropriate, or both? Pediatrics 104:187–194PubMedCrossRef
19.
Hahn GH, Koch A, Melbye M, Mølbak K (2005) Pattern of drug prescription for children under the age of four years in a population in Greenland. Acta Paediatr 94:99–106PubMedCrossRef
20.
Le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM (1999) Intervention research in rational use of drugs: a review. Health Policy Plan 14:89–102PubMedCrossRef
21.
22.
Madsen H, Anderson M, Halls J (2001) Drug prescribing among Danish children: a population-based study. Eur J Clin Pharmacol 57:159–165PubMedCrossRef
23.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332:133–138PubMedCrossRef
24.
McIntyre J, Conroy S, Avery A, Corns H, Choonara I (2000) Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 83:498–501PubMedCrossRef
25.
Moth G, Vedsted P, Schiøtz PO (2007) Identification of asthmatic children using prescription data and diagnosis. Eur J Clin Pharmacol 63:605–611PubMedCrossRef
26.
Niclasen BV-L (2006) Changes in drug prescription over a decade in an Arctic child population. Acta Paediatr 95:1456–1460PubMedCrossRef
27.
Rabe KF, Vermeire PA, Soriano JB, Maier WC (2000) Clinical management of asthma in 1999: the asthma insight and the reality in Europe (AIRE) study. Eur Respir J 16:802–807PubMedCrossRef
28.
Resi D, Milandri M, Moro ML; Emilia Romagna Study Group on the Use of Antibiotics in Children (2003) Antibiotic prescriptions in children. J Antimicrob Chemother 52:282–286PubMedCrossRef
29.
Rossi E, De Rosa M, Bonati M, Covezzoli A, Busca P, Addis A, Tognoni G, Gruppo di Lavoro USL (2001) La prescrizione farmaceutica pediatrica nell’ambito delle cure primarie. Rapporto dalla banca dati ARNO. G Ital Farm Clin 15:26–29
30.
Rossignoli A, Clavenna A, Bonati M (2007) Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000–2005. Eur J Clin Pharmacol 63:1099–1106PubMedCrossRef
31.
32.
Sanz E, Hernández MA, Ratchina S, Stratchounsky L, Peiré MA, Lapeyre-Mestre M, Horen B, Kriska M, Krajnakova H, Momcheva H, Encheva D, Martínez-Mir I, Palop V (2004) Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia). Eur J Clin Pharmacol 60:127–134PubMedCrossRef
33.
Schirm E, van den Berg P, Gebben H, Sauer P, de Jong-van den Berg L (2000) Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol 50:473–478PubMedCrossRef
34.
Scottish Intercollegiate Guidelines Network (SIGN) (1999) Management of sore throat and indication for tonsillectomy. A national clinical guideline. SIGN, Edinburgh, Scotland
35.
Scottish Intercollegiate Guidelines Network (SIGN) (2003) Diagnosis and management of childhood otitis media in primary care. A national clinical guideline. SIGN, Edinburgh, Scotland
36.
The U.S. Pharmacopeia Drug Utilization Review Advisory Panel (2000) Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. J Am Pharm Assoc (Wash) 40:538–545
37.
38.
World Health Organization/Action Programme on Essential Drugs (WHO/DAP) (1995) Operational research projects in DAP: an inventory. WHO/DAP
39.
Wong I, Sweis D, Cope J, Florence A (2003) Paediatric medicines research in the UK: how to move forward? Drug Saf 26:529–537PubMedCrossRef
Metadata
Title
Drug utilisation profile in the Italian paediatric population
Authors
Antonio Clavenna
Alessandra Berti
Lucia Gualandi
Elisa Rossi
Marisa De Rosa
Maurizio Bonati
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 2/2009
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0725-y

Other articles of this Issue 2/2009

European Journal of Pediatrics 2/2009 Go to the issue

Original Paper

First febrile convulsions: inquiry about the knowledge, attitudes and concerns of the patients’ mothers

Short Report

Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1

Short Report

A case of congenital agenesis of the right pulmonary artery presenting with hemoptysis and mimicking pulmonary hemosiderosis

Original Paper

Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

Original Paper

Analysis of 347 kindergarten-related injuries

Review

Acute paraplegia due to spinal arteriovenous fistula in two patients with hereditary hemorrhagic telangiectasia